-
Mashup Score: 3
Researchers developed a barcoded directed evolution system for engineered virus-like particles (eVLPs), creating a fifth-generation (v5) eVLP with enhanced production, transduction, and gene-editing efficiency. This system could pave the way for improved gene delivery vehicles in therapeutic applications.
Source: www.news-medical.netCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 6
Tempe, AZ, Nov. 12, 2024 – A comprehensive study from Arizona State University’s Research for Inclusive STEM Education (RISE) Center highlights significant mental health challenges affecting graduate science students.
Source: news.asu.eduCategories: General Medicine News, Future of MedicineTweet-
@CooperBioEdLab @Katey_Cooper @ASU_RISE_Center @ASU @BrownUniversity New research reveals what underlies the mental health crisis among science graduate students and calls for action to address key stressors #NBTintheNews via @asunews https://t.co/Yyqb6n8wzY https://t.co/Xvd3maoStq
-
-
Mashup Score: 2SCS Researcher Develops Metagenomic Profiling Method - 4 day(s) ago
A new k-mer sketching metagenomic profiler allows scientists to analyze genomic data more quickly and precisely than other profilers.
Source: www.cmu.eduCategories: General Medicine News, Future of MedicineTweet-
.@SCSatCMU researcher develops metagenomic profiling method #NBTintheNews https://t.co/94X3Ko2GHN https://t.co/AS9j25Oecx
-
-
Mashup Score: 12
Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor environments, with promising clinical results.
Source: www.news-medical.netCategories: General Medicine News, Future of MedicineTweet-
@UgiUslu @carlhjune @PennMedicine CAR T cell therapy breakthroughs bring new hope for treating solid tumors #NBTintheNews https://t.co/gAj0JRbCxX
-
-
Mashup Score: 19
Researchers at ETH Zurich have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.
Source: ethz.chCategories: General Medicine News, Future of MedicineTweet-
@randall_platt @olivier_belli @k_karava @ETH_en @ETH_BSSE @BRC_CH @UniBasel @NCCR_MSE Using CRISPR to decipher whether gene variants lead to cancer #NBTintheNews via @ETH_en https://t.co/PaLXxzNOgQ
-
-
Mashup Score: 19
Understanding how gene mutations influence protein-protein interactions across the interactome is critical to further diagnostic and drug discovery research.
Source: www.lerner.ccf.orgCategories: General Medicine News, Future of MedicineTweet-
@haiyuanyu @FeixiongCheng @CornellCALS @weillinstitute @CCLRI @CleClinicLCM @cwru @columbiacancer @ECNUER @BrighamWomens New AI tool predicts protein-protein interaction mutations in hundreds of diseases #NBTintheNews via @CCLRI https://t.co/OReWgMptuL https://t.co/xCuNWM4ufk
-
-
Mashup Score: 8
Applying the technology behind large language models to protein sequences is expediting the study and design of proteins
Source: www.synbiobeta.comCategories: General Medicine News, Future of MedicineTweet-
From sequence to function with protein language models #NBTintheNews via @SynBioBeta https://t.co/Y5rOn7j1kh
-
-
Mashup Score: 4Research Spotlight: Researchers Develop SCOPE to Improve Early-Stage Cancer Detection - 12 day(s) ago
Cesar M. Castro, MD, MSc, of the Department of Medicine and Center for Systems Biology at Massachusetts General Hospital, and Hakho Lee, PhD, of the Department of Radiology and Center for Systems Biology at Massachusetts General Hospital, are co-corresponding authors of a paper published in Nature Biotechnology, “Amplifying mutational profiling of extracellular vesicle mRNA with SCOPE.”
Source: www.massgeneral.orgCategories: General Medicine News, Future of MedicineTweet-
@MassGeneralNews @MGH_RI @harvardmed @IBS_media @kribb_pr @kaistpr @SKKUni1398 @HakhoLee_Lab Research spotlight: Researchers develop SCOPE to improve early-stage cancer detection #NBTintheNews via @MassGeneralNews https://t.co/MgAzfEU4ln https://t.co/utRMcBBH8i
-
-
Mashup Score: 8Validation testing of next-gen genome analysis platform reveals potentially disruptive tech - 13 day(s) ago
A collaborative study by researchers from Baylor College of Medicine and Illumina has showcased the exceptional capabilities of the DRAGEN (Dynamic Read Analysis for GENomics) platform in comprehensive …
Source: phys.orgCategories: General Medicine News, Future of MedicineTweet-
@sedlazeck @mehio_rami @SCatreux @srbehera11 @BCM_HGSC @illumina @bcmgenetics @bcmhouston @RiceCompSci Validation testing of next-gen genome analysis platform reveals potentially disruptive tech #NBTintheNews via @physorg_com https://t.co/ld2RbzNaMW https://t.co/IaS7lfJFVA
-
-
Mashup Score: 5
CIC bioGUNE leads the development of ReChb, the most advanced and versatile gene editing tool to date Scientists from CIC bioGUNE have created ReChb, a CRISPR tool that allows for more flexible and precise nucleic acid editing, thanks to ancestral sequence reconstruction (ASR). This breakthrough, recently published in Nature Biotechnology, has the potential to revolutionize nucleic acid editing, enhancing applications in biomedicine, gene therapy, and molecular diagnostics. Under the direction of Raúl
Source: www.cicbiogune.esCategories: General Medicine News, Future of MedicineTweet-
@CICbioGUNE @basque_for @Helmholtz_HIRI @BRforEM @YleniaJabalera @BeiselLab @IgorTascon .@CICbioGUNE leads the development of ReChb, the most advanced and versatile gene editing tool to date #NBTintheNews https://t.co/vQzlT1P5Bp https://t.co/4clhnGTC8L
-
@davidrliu @liugroup @broadinstitute @HarvardCCB @HHMINEWS @kochinstitute @AdityaRaguram Engineered virus-like particles evolve for superior gene delivery efficiency #NBTintheNews via @NewsMedical https://t.co/LObUsNsasy